163 related articles for article (PubMed ID: 7864817)
21. Isoform-selective interaction of cyclooxygenase-2 with indomethacin amides studied by real-time fluorescence, inhibition kinetics, and site-directed mutagenesis.
Timofeevski SL; Prusakiewicz JJ; Rouzer CA; Marnett LJ
Biochemistry; 2002 Jul; 41(30):9654-62. PubMed ID: 12135387
[TBL] [Abstract][Full Text] [Related]
22. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
23. Differential effect of selective cyclooxygenase-2 (COX-2) inhibitor NS 398 and diclofenac on formalin-induced nociception in the rat.
Euchenhofer C; Maihófner C; Brune K; Tegeder I; Geisslinger G
Neurosci Lett; 1998 May; 248(1):25-8. PubMed ID: 9665655
[TBL] [Abstract][Full Text] [Related]
24. Diclofenac and NS-398, a selective cyclooxygenase-2 inhibitor, decrease agonist-induced contractions of the pig isolated ureter.
Mastrangelo D; Wisard M; Rohner S; Leisinger H; Iselin CE
Urol Res; 2000 Dec; 28(6):376-82. PubMed ID: 11221916
[TBL] [Abstract][Full Text] [Related]
25. Suppression of prostaglandin synthesis with NS-398 has different effects on endocortical and periosteal bone formation induced by mechanical loading.
Li J; Burr DB; Turner CH
Calcif Tissue Int; 2002 Apr; 70(4):320-9. PubMed ID: 12004337
[TBL] [Abstract][Full Text] [Related]
26. Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines.
Hara A; Yoshimi N; Niwa M; Ino N; Mori H
Jpn J Cancer Res; 1997 Jun; 88(6):600-4. PubMed ID: 9263538
[TBL] [Abstract][Full Text] [Related]
27. Structure-based design of COX-2 selectivity into flurbiprofen.
Bayly CI; Black WC; Léger S; Ouimet N; Ouellet M; Percival MD
Bioorg Med Chem Lett; 1999 Feb; 9(3):307-12. PubMed ID: 10091674
[TBL] [Abstract][Full Text] [Related]
28. Involvement of cyclooxygenase 2 (COX-2) in intrinsic tone of isolated guinea pig trachea.
Charette L; Misquitta C; Guay J; Reindeau D; Jones TR
Can J Physiol Pharmacol; 1995 Nov; 73(11):1561-7. PubMed ID: 8789408
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.
Famaey JP
Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063
[TBL] [Abstract][Full Text] [Related]
30. Effects of nimesulide and indometacin on COX-1 and COX-2: a comparative study.
de Leval X; Dogné JM; Neven P; Labasse A; Delarge J; Reginster JY; Henrotin Y
J Pharm Belg; 1999; 54(3):89-90. PubMed ID: 10431478
[TBL] [Abstract][Full Text] [Related]
31. Molecular modelling of the differential interaction between several non-steroidal anti-inflammatory drugs and human prostaglandin endoperoxide H synthase-2 (h-PGHS-2).
Pouplana R; Lozano JJ; Ruiz J
J Mol Graph Model; 2002 Jan; 20(4):329-43. PubMed ID: 11858641
[TBL] [Abstract][Full Text] [Related]
32. Effects of non-steroidal anti-inflammatory drugs and cyclooxygenase-2 specific inhibitors on mediator release from rat peritoneal mast cells.
Lau HY; Stenton GR
Inflamm Res; 1998; 47 Suppl 1():S22-3. PubMed ID: 9561398
[No Abstract] [Full Text] [Related]
33. Nonsteroidal antiinflammatory drugs inhibit cyclooxygenase-2 enzyme activity but not mRNA expression in human macrophages.
Barrios-Rodiles M; Keller K; Belley A; Chadee K
Biochem Biophys Res Commun; 1996 Aug; 225(3):896-900. PubMed ID: 8780708
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of COX inhibitors against beta-amyloid-induced neurotoxicity in human neuroblastoma cells.
Ferrera P; Arias C
Neurochem Int; 2005 Dec; 47(8):589-96. PubMed ID: 16169124
[TBL] [Abstract][Full Text] [Related]
35. The COX-2 inhibitor NS-398 causes T-cell developmental disruptions independent of COX-2 enzyme inhibition.
Xu H; Izon DJ; Loftin C; Spain LM
Cell Immunol; 2001 Dec; 214(2):184-93. PubMed ID: 12088417
[TBL] [Abstract][Full Text] [Related]
36. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
[TBL] [Abstract][Full Text] [Related]
37. Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach.
Gretzer B; Ehrlich K; Maricic N; Lambrecht N; Respondek M; Peskar BM
Br J Pharmacol; 1998 Mar; 123(5):927-35. PubMed ID: 9535022
[TBL] [Abstract][Full Text] [Related]
38. Detergents profoundly affect inhibitor potencies against both cyclo-oxygenase isoforms.
Ouellet M; Falgueyret JP; Percival MD
Biochem J; 2004 Feb; 377(Pt 3):675-84. PubMed ID: 14510637
[TBL] [Abstract][Full Text] [Related]
39. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
Elder DJ; Halton DE; Hague A; Paraskeva C
Clin Cancer Res; 1997 Oct; 3(10):1679-83. PubMed ID: 9815550
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase.
Copeland RA; Williams JM; Giannaras J; Nurnberg S; Covington M; Pinto D; Pick S; Trzaskos JM
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11202-6. PubMed ID: 7972034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
